Evidence map›Paper›PMID 40660987›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Effects of PEG-IFN-α treatment on the expression of CD

Y P Li, C R Liu, X Zhang, N Huang, W Zhang, L Yang, S S Dang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Y P LiDepartment of Infection Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004,China.
C R LiuDepartment of Infection Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004,China.
X ZhangDepartment of Infection Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004,China.
N HuangBiological Diagnostic Centre, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
W ZhangDepartment of Laboratory Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
L YangDepartment of Infection Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004,China.
S S DangDepartment of Infection Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004,China.

Funding

National Key Research and Development Program 2023YFC2308105Shaanxi Provincial Natural Science Basic Research Program 2023-JC-YB-770Xi'an Jiaotong University Medical "Basic-Clinical" Integrated Innovation Project YXJLRH2022067
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCD8-Positive T-LymphocytesHepatitis B, ChronicInterferon-alphaPolyethylene GlycolsProgrammed Cell Death 1 ReceptorAdultFemaleFlow CytometryHepatitis B Surface AntigensHumansMaleMiddle AgedNK Cell Lectin-Like Receptor Subfamily BRetrospective StudiesAntiviral AgentsHepatitis B Surface AntigensInterferon-alphaNK Cell Lectin-Like Receptor Subfamily BPDCD1 protein, humanPolyethylene GlycolsProgrammed Cell Death 1 Receptor

Identifiers

PMID40660987
PMCPMC12861853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.